Table 2

Clinical characteristics of longitudinal cohort

TimeNoDx→NoDxNoDx→DMPreDM→DMP
N191920
Age, yearsTime 142.50 (8.26)47.84 (8.58)47.69 (8.68)0.095
Time 247.60 (8.75)52.76 (8.50)52.21 (8.84)0.141
BMI, kg/m2Time 133.10 (5.60)35.40 (7.66)35.56 (9.11)0.540
Time 233.92 (5.48)36.63 (9.41)35.44 (8.63)0.585
Glucose, mg/dLTime 189.42 (4.14)93.26 (9.13)110.55 (6.06)<0.001
Time 289.58 (6.13)125.53 (40.68)131.55 (45.81)0.001
LDL, mg/dLTime 1132.63 (38.20)133.05 (31.06)118.45 (32.13)0.315
Time 2123.53 (33.66)119.42 (37.89)119.15 (36.06)0.915
HDL, mg/dLTime 150.95 (14.25)50.05 (11.97)42.55 (10.21)0.070
Time 255.84 (11.55)53.47 (15.21)44.80 (11.01)0.022
Nonsmoking, n (%)Time 15 (50.0)6 (33.3)10 (55.6)0.389
Time 25 (35.7)8 (50.0)8 (44.4)0.783
White race, n (%)7 (36.8)5 (26.3)8 (40.0)0.645
Women, n (%)14 (73.7)12 (63.2)14 (70)0.776
  • Mean (SD) is shown for continuous variables and analyzed by one-way ANOVA, unless otherwise indicated. χ2 goodness-of-fit test was used to analyze differences for categorical variables. DM, diabetes; NoDx, euglycemia; PreDM, prediabetes.